Ideally a partnership agreement can be made to carry this forward. Looks like the recent BOD appointment was done with this in mind. The more pre-clinical data available will assist in negotiations.
- Forums
- ASX - By Stock
- ATX
- Ann: ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH
Ann: ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH, page-7
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.38M |
Open | High | Low | Value | Volume |
14.0¢ | 14.0¢ | 13.8¢ | $34.30K | 245.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 65549 | 13.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.0¢ | 85150 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65549 | 0.135 |
9 | 283481 | 0.130 |
3 | 227518 | 0.125 |
1 | 70001 | 0.120 |
2 | 266206 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.140 | 85150 | 2 |
0.145 | 209082 | 5 |
0.150 | 440438 | 9 |
0.155 | 459325 | 4 |
0.160 | 221074 | 5 |
Last trade - 10.57am 20/08/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |